Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private

BSE1689.00-0.05 (0 %)

PREV CLOSE ( ) 1689.05

OPEN PRICE ( ) 1699.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 9924

TODAY'S LOW / HIGH ( )1685.00 1703.00

52 WK LOW / HIGH ( )1303 2029

NSE1689.101.5 (+0.09 %)

PREV CLOSE( ) 1687.60

OPEN PRICE ( ) 1696.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1689.10 (8)

VOLUME 171615

TODAY'S LOW / HIGH( ) 1683.30 1703.50

52 WK LOW / HIGH ( )1385.75 2030

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

8873.92

7515.09

5552.33

5049.02

5968.85

Adjustment

2085.55

1872.25

1957.78

1022.73

-461.72

Changes In working Capital

71.74

-56.36

-299.20

-3024.24

-942.09

Cash Flow after changes in Working Capital

11031.21

9330.98

7210.91

3047.51

4565.05

Cash Flow from Operating Activities

9024.50

8006.12

6256.12

1701.35

3147.85

Cash Flow from Investing Activities

-2958.96

-4038.30

-9617.88

23.20

-2306.76

Cash Flow from Financing Activities

-5796.70

-3854.85

3565.38

-1383.85

-874.23

Net Cash Inflow / Outflow

268.84

112.96

203.62

340.69

-33.14

Opening Cash & Cash Equivalents

882.15

769.34

565.44

224.74

257.52

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

-0.08

-0.16

0.29

0.01

0.36

Closing Cash & Cash Equivalent

1150.91

882.15

769.34

565.44

224.74